The adhesion and degranulation promoting adaptor protein (ADAP) is a multifunctional scaffold involved in many different signaling pathways that are important for the function of T cells, including the inside-out and outside-in signaling of integrins, the activation of NF-kB, and the subsequent production of proinflammatory cytokines (e.g., on ADAP. Our data identify ADAP as a potential molecular target for T cell subset-specific therapeutic interventions.
Introduction
ADAP serves as a multifunctional protein scaffold, whose expression is restricted to cells of the hematopoietic linage. Next to its well-documented expression in T cells [1] , ADAP has been shown to be expressed in platelets [2] , myeloid cells [3] , NK cells [4] , and pre-B cells (but not in mature splenic B cells), as well as in unconventional T cells, such as NKT, CD8aa, and TCRgd T cells [5] . The molecule plays a crucial role in the development of TCRab T cells. Here, ADAP deficiency of CD4/CD8 double-positive thymocytes results in reduced interaction with APCs, reduced CD69 up-regulation and proliferation, and an overall impaired positive and negative selection [6] .
The immunologic functions of ADAP are best described for T cells, where it is known to be involved in the mediation of TCRgenerated signals. Together with SKAP55, to which a fraction is constitutively bound and to which it also stabilizes [7] [8] [9] [10] , ADAP facilitates a conformational change and hence, activation of integrins, a process known as inside-out signaling. Furthermore, the ADAP/SKAP55 module mediates signals generated from the interaction of integrins with their ligands on other cells, known as outside-in signaling [6, 9, [11] [12] [13] . This is a prerequisite for firm adhesion, necessary not only in transmigration but also in formation of the immunologic synapse during the contact between naïve T cells and APCs [14, 15] . Furthermore, it has also been reported that ADAP is involved in the integrin signaling downstream of chemokine receptors, such as CCR7 and CXCR4; hence, its mediator role is not exclusively restricted to TCR signaling [12, 15] .
T cells lacking ADAP have been shown to respond to TCR activation with reduced expression of the early activation marker CD69, as well as CD25, the high-affinity IL-2Ra. Moreover, their proliferative response to TCR stimuli was markedly reduced [11, 13] . This was explained by the fact that ADAP, together in a complex with the CBM signalosome, is important for the activation of the transcription factor NF-kB, which subsequently leads to the production of proinflammatory cytokines, such as IL-2 and IFN-g [16, 17] . The ADAP-Carma1 module has also been shown to be important in the regulation of cyclin-dependent kinase 2 and cyclin E, demonstrating its role in the cell-cycle progression of T cells [18] .
In animal models of heart and intestinal allograft transplantations, ADAP deficiency improved the survival of the grafts significantly, emphasizing the crucial role of ADAP in the induction of T cell-mediated immunity [19, 20] . Moreover, we have demonstrated that ADAP deficiency ameliorates experimental autoimmune encephalomyelitis in mice, a model strongly relying on CD4 + T cells, although surprisingly, not in a T cell-intrinsic manner [21] . Interestingly, a recent finding also suggests a more regulatory role for ADAP. In the signaling downstream of the TbRI, it is involved in the positive-feedback loop of the TbRI-TNFR-associated factor 6-TGF-b-activated protein kinase-Mothers against decapentaplegic homolog 3 (SMAD3) pathway in CD8 + T cells, ultimately resulting in increased mortality of Adap 2/2 mice during IAV infection, as a result of an aberrant, excessive immune response [22] . However, in this study, the status and function of CD8 + T cells were not addressed. Furthermore, the ADAP-SKAP55 module regulates-via NFATc1-the expression of the inhibitory molecule programmed cell death protein 1 on T cells, thereby reducing the cytotoxicity of CD8 + T cells in a mouse tumor model [23] . Recently, the importance of ADAP for the generation of memory phenotype CD8 + T cells has been demonstrated [24] . Apart from these published data, the impact of ADAP deficiency on T cell function in the context of diseases or infections remains largely elusive.
As a result of its fundamental functions in T cells, ADAP may be considered a potential immune-modulatory drug target. However, taken into account its expression in a plethora of immune cells, its complex involvement in various pathways, as well as its contradicting roles in certain settings, the consideration of experimental approaches focusing on the therapeutic manipulation of ADAP-mediated immune responses necessarily relies on a more thorough understanding of its functions in certain immune cell subsets. Of note, despite 3 decades of research in the field, only very few published data exist on the role of ADAP in T cell activation and function, discriminating between CD4 + and CD8 + T cells. Whereas Mueller et al. [25] discriminated between both subsets and analyzed the role of ADAP in the activation and expansion of CD4 + T cells in vitro and in vivo, using the DO11.10-transgenic TCR model, there are no comparable data on CD8 + T cells. Here, we set out to do a comparative analysis of T cell subsetspecific effects of ADAP deficiency in vitro and in vivo. Our findings reveal that CD4 + T cell functions rely heavily on ADAP, whereas the impact of ADAP deficiency on CD8 + T cell activation, expansion, and execution of effector function is less pronounced and does not impair their overall capacity to eliminate pathogens during in vivo infections.
MATERIALS AND METHODS

Animals
Adap 2/2 [11] , OT-I [26] , Adap 2/2 3 OT-I 3 CD90.1 (all bred in-house), and C57Bl/6J (Harlan) mice were maintained under specific pathogen-free conditions in environmentally controlled clean rooms in the Animal Facility at the Helmholtz Center for Infection Research (Braunschweig, Germany) and were used for the study at an age of 10-14 wk. All animal experiments were conducted according to the institutional guidelines, and the study was ethically approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (33.9-42502-04-10/0256).
Lm infection
OVA-expressing Lm (LmOVA; strain 10403S) were kindly provided by Dirk Busch [27] . One day before the infection of the mice, an overnight culture was inoculated. On the next day, the main culture was inoculated with the overnight culture and grown for 3 h. The bacterial concentration (CFU/ml) was determined by OD at 600 nm measurement and diluted to the desired infection dose of 2 3 10 4 CFU/mouse in sterile PBS. Mice were infected intravenously via the tail vein and monitored on a daily basis.
IAV infection
IAV (strain A/WSN/1933 H1N1), carrying the OT-I corresponding OVA peptide (OVA [257] [258] [259] [260] [261] [262] [263] [264] ; N-SIINFEKL-C), was provided by Alina Boesteanu (University of Pennsylvania, Philadelphia, PA, USA) and titrated in mice to determine a sublethal infection dose. Mice were anesthetized by intraperitoneal injection of a mixture of ketamine and xylazine. The virus solution (25 ml; 1:1500 in sterile PBS) was applied to the mice intranasally with a micropipette. During the course of the infection, the mice were monitored daily.
Cell preparation
Spleens were harvested from animals and rinsed with cold PBS using a syringe, while squeezing the organ with a forceps. Subsequently, erythrocytes were lysed with standard ammonium-chloride-potassium lysing buffer, and the cell suspension was passed through a 100 mm cell strainer. The absolute cell numbers were determined by counting Trypan blue-stained cells in a hemocytometer. Leukocytes were washed and stored on ice until further use. supplemented with 1% BSA (Carl Roth, Karlsruhe, Germany) and 25 mM HEPES, pH 7.4] was added to the upper chamber, and 500 ml assay medium, with or without chemokine (500 ng/ml CXCL12 or 500 ng/ml CCL21; R&D Systems), was added to the lower chamber. The Transwell plates were kept at 37°C in 5% CO 2 for 2 h. Cells that migrated to the bottom chamber were collected, counted, and calculated as percent of input.
In vitro T cell activation assays
Western blot
Splenic CD3 + , CD8 + and CD4 + lymphocytes were purified using T cell isolation kits and autoMACS magnetic separation system (Miltenyi Biotec). Cell lysis was performed as described previously [10, 28] . Equivalent amounts of protein (determined by Bradford assay (50 mg total protein; Carl Roth) were separated by SDS-PAGE and transferred to nitrocellulose. Western blots were conducted with the indicated antibodies and developed with the appropriate HRP-conjugated secondary antibodies (Dianova, Hamburg, Germany) and the Luminol detection system (Carl Roth). The following antibodies and sera were used: the anti-murine ADAP sheep serum (kindly provided by Gary A. Koretzky, University of Pennsylvania, Philadelphia, PA, USA) [29] ; anti-ADAP mAb; anti-SKAP55 mAb (both from BD Biosciences); anti-SKAP-HOM rabbit serum [28] ; and anti-b-actin mAb (Sigma-Aldrich, St. Louis, MO, USA).
Adoptive CD8 + T cell transfer CD8 + T cells were isolated by MACS using the CD8a + T Cell Isolation Kit (Miltenyi Biotec), according to the protocol provided by the manufacturer. The isolated cells were stained with CFSE (final concentration 1.5 mM) for proliferation analysis later on. The purity of the cells was determined by flow cytometry and was .90%. Cells (4 3 10 6 ) were adoptively transferred to WT C57BL/6J recipient mice by intravenous injection into to the tail vein.
Cell staining and flow cytometry
For flow cytometric analysis, cells were first stained with anti-CD16/32 antibody (BioLegend) to prevent unspecific antibody binding to the cell surface, followed by staining with antibodies against CD3e, CD4, CD8a, CD19, CD25, CD43, CD69, and IFN-g (all BioLegend) and CD44, CD62L, CD90.1, and granzyme B (all eBioscience, San Diego, CA, USA). For live/dead discrimination LIVE/DEAD Fixable Blue (Thermo Fisher Scientific, Waltham, MA, USA) was used. The cells were fixed with 2% paraformaldehyde and flow cytometrically assessed with a BD LSRFortessa (BD Biosciences).
Intracellular staining
To stain for cytokine production, cells were taken into culture and stimulated with OVA 257-264 peptide or PMA/ionomycin for 5 h. One hour after restimulation, Brefeldin A (Sigma-Aldrich) was added (5 mg/ml) to prevent cytokine exocytosis. After washing, staining for extracellular markers, and fixation, the cells were permeabilized using 0.1% IGEPAL CA-630 (SigmaAldrich) and stained for 30 min at 4°C with antibodies against the cytokines of interest. Assessment of intracellular ADAP levels by flow cytometry was performed by cell permeabilization with 0.1% IGEPAL CA-630, staining for 60 min at room temperature with an aADAP polyclonal sheep serum [29] , and a secondary staining for 30 min with an FITC-conjugated polyclonal donkey anti-sheep IgG antibody (Abcam, Cambridge, United Kingdom).
In vivo CTL assay . Peptide-pulsed (0.01-1 mg/ml NP 366-374 ) and nonpulsed control cells were mixed in a 1:1 ratio, and 2 3 10 7 cells of this suspension were transferred to the previously infected animals. Twelve hours later, the animals were euthanized and their splenocytes isolated. The relative amounts of CFSE hi (i.e., peptide pulsed) and CFSE lo (i.e., "empty" control) cells were determined by flow cytometry.
Specific lysis was calculated as previously described [30] .
Statistics
Results are represented as means 6 SEM. For statistical analysis, GraphPad Prism (GraphPad Software, La Jolla, CA, USA) was used.
RESULTS
ADAP expression level is comparable in CD4 + and CD8 + T cells
The expression of ADAP has previously been shown in spleen, thymus, and peripheral blood leukocytes [5] . However, despite its well-established functions in T cells, prior studies did not address potential differences in the level of ADAP expression in different cellular subsets. Thus, to determine the expression of ADAP in a T cell subset-specific manner, splenic CD4 + and CD8 To corroborate the FACS data, ADAP expression was also assessed by Western blot analysis. As expected, CD4 + and CD8 + T cells stained positive for ADAP. As it has been shown that ADAP stabilizes the expression of its binding partners SKAP55 and SKAP-HOM [8, 28] , cell lysates were also stained with antibodies specific for these 2 molecules. In concordance with previous findings, ADAP deficiency markedly reduces the amount of SKAP55 and SKAP-HOM in both T cell subsets (Fig. 1C ).
As it has been reported that the CD3e expression level differs in CD4 + and CD8 + T cells and that this affects their propensity for activation [32] [33] [34] , we also quantified CD3e expression in both T cell subsets isolated from WT and Adap 2/2 mice. As expected, CD4 + T cells expressed higher amounts of CD3e on their surfaces compared with CD8 + T cells. Interestingly, ADAP deficiency is associated with an overall decreased CD3e expression on both T cell subsets ( Fig. 1D ), which might be attributed to the developmental defects shown for Adap 2/2 T cells [5] .
Activation and proliferation of CD4 + T cells are more affected by ADAP deficiency than their CD8
+ counterparts
The significance of ADAP in T cell signaling downstream of the TCR has been demonstrated before using in vitro T cell stimulation assays, followed by staining for the expression of the early activation marker CD69, the high-affinity IL-2Ra (CD25), as well as analyzing T cell proliferation [11, 13] . However, for these studies, the entire polyclonal T cell pool was used, and so far, the effect of ADAP deficiency on T cell activation was not investigated in a subset-specific manner. To clarify whether ADAP deficiency differentially affects CD4 + and CD8 + T cell activation and function, we isolated both subsets from spleens of WT and Adap 2/2 mice, followed by in vitro stimulation and subsequent analysis of their activation profile.
Strikingly, whereas CD69 expression was equally reduced in both T cell subsets in response to TCR-induced activation when ADAP was lacking ( Fig. 2A) , the shedding of the homing receptor L-selectin (Fig. 2B) (Fig. 2C ).
This is well in line with reduced proliferation of Adap 2/2 CD4 + T cells, whereas CD8 + T cell proliferation appears not to be dependent on ADAP under these experimental conditions (Fig.  2D) . Taken together, our data show that CD4 + T cell activation is more dependent on ADAP than that of CD8 + T cells.
ADAP is crucial for chemokine receptor-induced adhesion of T cells but dispensable for TCR-stimulated adhesion in CD8 + T cells
Previous studies clearly indicated the involvement of ADAP in T cell adhesion in response to TCR activation [35] . Furthermore, a crucial role for ADAP in chemokine receptor-induced integrin activation has been demonstrated. For CXCR4, this has been shown in human primary T cells upon down-regulation of ADAP and for CCR7, in mouse splenic T cells [15, 36] . Again, these studies were performed with the entire polyclonal T cell pool and did not distinguish between the CD4 + and CD8 + T cell subset. 
CD4
+ and CD8 + T cells from WT or Adap 2/2 mice were sorted, and their adhesion to the LFA-1 ligand ICAM-1 in response to activation was assessed. The cells were activated via the TCR (aCD3e mAb stimulation) or via the chemokine receptors CCR7 (treatment with CCL21) and CXCR4 (treatment with CXCL12), respectively. Treatment with PMA or MnCl 2 , both known to induce T cell adhesion, independent of cell-surface receptor engagement, hence, bypassing ADAP, was used as a positive control. In this setting, Adap 2/2 CD4 + T cells showed a significantly reduced adhesion to ICAM-1-coated surfaces in response to increasing concentrations of CD3e mAb. This was also the case when the cells were activated via chemokine receptors (Fig. 3A) . Strikingly, and in marked contrast to the CD4 + T cell subset, adhesion of CD8 + T cells was not affected by ADAP deficiency in response to TCR ligation but clearly, when cells were activated by chemokines (Fig. 3B ). In concordance with these findings, also, migration toward chemokine gradients was impaired in Adap 2/2 CD4 + ( Fig. 3C ) and CD8 + (Fig. 3D ) T cells when tested in an in vitro system.
Together, these data show that ADAP is required for mediating adhesion downstream of the TCR in CD4 + T cells, whereas this is not the case in CD8 + T cells. Interestingly, chemokine receptor-stimulated adhesion and migration appear to rely on ADAP, irrespective of the T cell subtype.
ADAP is dispensable for antigen-specific CD8 + T cell activation in vitro Next, we analyzed the role of ADAP in a clonal TCR-transgenic setting, allowing the antigen-specific stimulation of T cells using peptide agonists. OT-I and OT-II mice generate CD8 + and CD4 + T cells, respectively, which express a TCR specifically responding to peptides derived from the model antigen OVA [26, 37] . Upon breeding of Adap 2/2 3 OT-II mice, we observed that Adap
OT-II TCR-transgenic mice produced virtually no CD4 + T cells (Supplemental Fig. 1A and B) . This has been reported for other TCR-transgenic systems, such as H-Y and AND [6] . As a result of the dramatic impact of ADAP deficiency on the thymic development of CD4 + OT-II T cells in Adap 2/2 3 OT-II mice, these mice turned out to be inappropriate as donors for Adap 2/2 CD4 + T cells with defined antigen specificity. On the other hand, Adap 2/2 OT-I mice (Adap 2/2 3 OT-I) produced CD8 + T cell numbers comparable with their WT counterparts, even though their numbers were drastically decreased in the thymi of the mice. Furthermore, even in these OT-I mice, the numbers of CD4 + T cells were significantly lower in the Adap 2/2 than in their Interestingly, and in contrast to nonantigen-driven stimulation (Fig. 2) 4A ). This could be attributed to the strong signaling through the high-affinity OT-I TCR. The shedding of CD62L (L-selectin) was already slightly reduced in vehicle controls. The same relation was kept independent of the peptide concentration used for CD8 + T cell stimulation (Fig. 4B ). The expression of CD25 was significantly reduced on Adap 2/2 CD8 + T cells at extremely low amounts of peptide (10 pg/ml); however, at higher concentrations, CD25 expression was comparable with that detected on WT CD8 + T cells (Fig. 4C) . Consequently, T cell proliferation in response to antigen-specific stimulation was not affected by ADAP deficiency (Fig. 4D) . Taken together, our data suggest that in this in vitro setting, ADAP is largely dispensable for the activation and proliferation of OT-I TCR-transgenic CD8 + T cells.
IFN-g production is impaired in Adap 2/2 CD8 + T cells, whereas activation, expansion, and pathogen clearance are only marginally affected in vivo An effective immune response against the intracellular bacterial pathogen Lm relies heavily on the cytotoxic effects exerted by CD8 + effector T cells, which makes it a versatile vehicle for probing CD8 + T cell responses [38] . Thus, to translate our in vitro findings to a more relevant in vivo setting, we analyzed the role of ADAP in CD8 + T cells in Lm-infected mice. To this end, Adap 2/2 and WT OT-I-transgenic mice were used as donors for adoptive CD8 + T cell transfers into WT recipients. One day after the transfer, the recipient mice were infected with recombinant Listeria that express the model antigen OVA (LmOVA), thereby being equipped to activate the engrafted OT-I TCR-transgenic CD8 + T cells. Two and 4 d postinfection, animals were euthanized, and donor CD8 + T cells were re-isolated from the spleens of recipient mice and analyzed for the expression of selected activation markers, dependent on the presence or absence of ADAP.
As summarized in Fig. 5 , activation of the transferred OT-I TCR-transgenic CD8 + T cells was readily detectable, proofing their proper in vivo activation by LmOVA. Progression to effector and memory cells was analyzed by means of the expression of CD43 and CD44, respectively. The CD43 expression level on CD8 + T cells was similar for both genotypes at any time point analyzed (Fig. 5A) . Interestingly, more Adap 2/2 CD8 + T cells were CD44 hi compared with their WT counterparts on d 2 postinfection; albeit, this difference was gone on d 4 postinfection (Fig. 5B) . Therefore, general progression to effector and memory phenotype seemed not to be affected in Adap 2/2 CD8 + T cells. Significantly lower numbers of Adap 2/2 CD8 + T cells stained positive for CD25 on d 2 postinfection. As CD25 is crucial only in the early phase of the T cell expansion, the frequency of CD25 + cells had drastically decreased in Adap 2/2 and WT CD8 + T cells at the later time point. Here, the difference between the genotypes was lost (Fig. 5C ). Well in line with the positive correlation of CD25 expression and T cell proliferation, Adap 2/2 CD8 + T cells displayed delayed proliferation following in vivo pathogen encounter (Fig. 5D) . However, at d 4 postinfection, almost all transferred CD8 + T cells had undergone extensive proliferation, independent of ADAP expression, and when looking at the expansion of the transferred CD8 + T cells in infected mice, the Adap 2/2 CD8 + T cells seemed even to outnumber the WT CD8 + T cells. Together, these findings suggest that despite delayed CD25 up-regulation and proliferation in the early phase following in vivo antigen encounter, the observed differences equalize with time. Thus, ADAP appears to be largely dispensable for the activation and expansion of OT-I TCR-transgenic CD8 + T cells in the LmOVA infection model. Next to its role in the activation/proliferation of CD8 + T cells, we also investigated the impact of ADAP deficiency on effector cell differentiation. The effector function of transferred cells was assessed by staining for granzyme B and the proinflammatory cytokine IFN-g ( Fig. 5E and F, respectively). Granzyme B production in transferred CD8 + T cells followed the same pattern of the above-described markers, i.e., lower frequency of granzyme B expressing cells in the Adap 2/2 group at d 2 postinfection and equally high granzyme B expression in CD8 + T cells, irrespective of the ADAP genotype, at the later time point. In direct contrast, we found equal frequencies of IFN-g-producing CD8
+ T cells early on after pathogen encounter but an impaired expansion of IFN-g + effector cells when CD8 + T cells are deficient for ADAP. Next, we confirmed our findings in another infection model. IAV causes a local infection of the airways and the bronchi, in contrast to the systemic LmOVA infection. As in the case of Listeria infection, the immune response against this viral pathogen relies strongly on the cytotoxic effects of specific CD8 + T cells [39, 40] . Adap 2/2 OT-I TCR-transgenic CD8 + T cells were transferred to WT recipient mice. On the day following the transfer, the mice were infected intranasally with recombinant IAV expressing the OVA 257-264 peptide (IAV-OVA). Seven days postinfection, lymphocytes form the lungs of these animals were isolated, stained, and analyzed by flow cytometry. Whereas the frequency of CD43 + Adap 2/2 CD8 + T cells was marginally, but significantly, reduced compared with their WT counterparts (Fig. 6A) , no ADAP-related difference was observed for the amount of CD44 hi T cells (Fig. 6B) . Hence, progression to effector and memory phenotype seemed not to be affected in Adap 2/2 CD8 + T cells. In support of this, CD8 + T cells showed strong proliferation following in vivo antigen encounter, irrespective of the genotype, and no significant difference in the expansion of the transferred cell was detectable 7 d after influenza infection (Fig. 6C) . The effector function of the transferred CD8 + T cells was assessed by staining for granzyme B and IFN-g. Whereas there were no differences detectable in the frequency of granzyme B-producing cells (Fig. 6D) , Adap
2/2
T cells showed a markedly decreased frequency of IFN-g + cells (Fig. 6E) , which is in concordance with the data obtained from the Listeria infection model.
Of note, the reduced frequency of IFN-g + CD8 + T cells had no impact on pathogen clearance. This was apparent in the Listeria infection, where the Adap 2/2 transferred cells were able to reduce the bacterial burden in livers comparable with their WT counterparts (Fig. 7A) . As a control, mice transferred with WT CD8 + T cells, but infected with non-OVA-transgenic Listeria (Lm wt), were not able to control the pathogen. To assess whether Adap 2/2 CD8 + T cells are able to clear the pathogen efficiently, in case ADAP is, as well, absent in CD4 + T cells, Lm infections were performed in conventional Adap 2/2 mice lacking ADAP in in Listeria-infected WT mice (Fig. 7A) , as well as Listeria infections in Adap 2/2 mice (Fig. 7B) , revealed a marginally impaired containment of the bacterial pathogen, cytotoxic capacity of CD8 + CTLs in conventional Adap 2/2 mice following IAV infection was comparable with that observed in WT animals ( Fig. 7C) , pointing at the efficient induction of antiviral CTL, even in the absence of ADAP. Taken together, our comprehensive data collected in in vitro and in vivo settings show for the first time that ADAP plays a pivotal role in CD4 + T cells, whereas it is largely dispensable for the activation, expansion, and establishment of effector functions in CD8 + T cells.
DISCUSSION
A lot of data has been compiled in recent years, and the importance of ADAP in T cell signaling is well established. Furthermore, the role of ADAP in the development, selection, and resulting cellularity of CD4 + and CD8 + T cells in the periphery has been studied extensively. Interestingly though, most studies did not distinguish between CD4 + and CD8 + T cells when analyzing functional aspects. In this study, we set out to investigate the role of ADAP in T cell activation and function in a subset-specific manner. Analysis of ADAP expression by flow cytometry revealed comparable levels of the protein in CD4 + and CD8 + T cells (Fig.  1A) . However, Western blot analysis of ADAP in T cells revealed a stronger signal in CD8 + T cells than in CD4 + T cells (Fig. 1C) . Whereas we cannot provide a full explanation for this discrepancy, we may speculate that the up-to-10% contaminating cells included in the MACS-purified T cell preparations used for Western blot analysis may account for the observed difference. In contrast, FACS analysis on gated CD4 + and CD8 + T cells allows for the analysis of well-defined (i.e., pure) T cell subsets. As we FACS analyzed ADAP expression in CD4 + and CD8 + T cells obtained from 10-14 individual mice (compared with a pool of T cells purified from 4 for 5 mice analyzed by Western blot) and as in contrast to Western blot analysis, intracellular staining enables detection of ADAP in its native form, which is, from the biologic point of view, most relevant, we consider the FACS data to be more robust. When we analyzed the impact of ADAP deficiency on the response of the different T cell subsets to TCR stimulation, the results were unexpected. Previous studies performed on the entire polyclonal CD4 + and CD8 + T cell population revealed that TCR-induced activation strongly relies on the presence of ADAP [11, 13] . However, these analyses did not distinguish between different T cell subsets and thereby, were not able to detect that mainly Adap 2/2 CD4 + T cells show impaired response to in vitro TCR activation, whereas Adap 2/2 CD8 + T cell responses remain largely normal in these settings ( Fig. 2A-D) . It has been reported that adhesion of Adap 2/2 T cells to ICAM-1 (a ligand for LFA-1) is reduced when the cells were stimulated via the TCR or the chemokine receptors CCR7 and CXCR4 [15, 35, 36] . When we analyzed binding to ICAM-1 in the CD4 + versus CD8 + T cell subsets, TCR-activated (aCD3e) Adap 2/2 CD4 + T cells showed markedly reduced adhesion, whereas their CD8 + counterparts were indistinguishable from the WT controls. This further emphasizes that CD8 + T cell function is less dependent on ADAP. Interestingly, when stimulated via CCR7 or CXCR4, loss of ADAP markedly decreased adhesion of both T cell subsets to ICAM-1 (Fig. 3A and B) . We observed similar effects of ADAP deficiency on both T cell subtypes in migration toward chemokine gradients in an in vitro Transwell system ( Fig. 3C and D) , This further emphasizes the importance of the adaptor molecule in chemokine receptor-mediated adhesion and migration.
Differences in signaling, activation, and adhesion of CD4 + and CD8 + T cells have been attributed to the lower expression level of CD3 on CD8 + T cells [32] [33] [34] . Furthermore, in our hands, CD8 T cells, independent of their subtype, expressed slightly less CD3 compared with the WT control cells (Fig. 1C) . Nevertheless, these findings cannot explain the differential dependence of the T cell subsets on ADAP.
The most promising fact to explain reasonably the observed subset-specific differences is their differential prerequisites for the kinetics of antigen recognition [41] [42] [43] . Whereas CD4 + T cells require sustained TCR signaling for optimal activation and progression to effector function [44] [45] [46] , their CD8 + counterparts only require a brief encounter with cognate antigen, basically putting them into a self-reliant autopilot mode [47] [48] [49] [50] . Our data provide evidence that ADAP is important for mediating these sustained and strong TCR signals required for proper CD4 + T cell activation and function. However, ADAP seems to be a crucial part in the downstream signaling of chemokine receptors, leading to integrin activation, irrespective of the T cell subtype.
To reduce effects from the polyclonal nature of T cell pools, we aimed to reproduce the results obtained in the activation experiments using the OT-I and OT-II TCR-transgenic model. Unfortunately, Adap 2/2 OT-II TCR-transgenic mice produced extremely small numbers of CD4 + T cells (Supplemental Fig. 1) , which made the model not feasible for further experiments. However, this also highlights the importance of ADAP in the selection process of T cells, as already shown in other TCRtransgenic models, such as H-Y and AND [5, 6] , emphasizing ADAP's distinct importance for CD4 + T cells. On the other hand, Mueller et al. [25] encounter, whereas all other analyzed markers showed little to no difference between Adap 2/2 and WT cells (Fig. 5A-D) .
Interestingly, although Adap 2/2 CD8 + T cells showed a slight impairment in their early proliferative response, this was compensated later on, and their actual number exceeded their WT counterparts (Fig. 5D) . The initially reduced number of CD25-expressing cells and thus, an impaired early response to the T cell growth factor IL-2 might explain the proliferative defects of the KO cells early on.
In the in vivo settings, cells were also stained for IFN-g production, and interestingly, less Adap 2/2 CD8 + T cells responded with production of this effector cytokine (Fig. 5F ). Nevertheless, despite reduced IFN-g production, the Adap 2/2 cells were not impaired in bacterial clearance, as demonstrated by the effective control of the bacterial burden in the infected mice (Fig. 7A) Under their experimental conditions, Adap 2/2 mice experienced a strong cytokine storm, and they found considerably higher levels of IFN-g mRNA in the lungs of the Adap 2/2 animals compared with WT controls. In contrast to this, we found less IFNg-producing Adap 2/2 OT-I TCR-transgenic CD8 + T cells in the lung of influenza-infected mice. To explain this discrepancy, it is important to note that there were several differences regarding the experimental setup between both studies. Whereas Li et al. [22] used a comparably high infection dose (50% lethality in WT mice) and performed influenza infection in conventional Adap 2/2 mice, we used a sublethal dose, causing a mild influenza infection that was sufficient for the activation of adoptively transferred Adap 2/2 CD8 + T cells in an otherwise ADAP-sufficient host. Most importantly, in contrast to our data, Li et al. [22] did not directly analyze whether increased levels of IFN-g in the lung of influenzainfected Adap 2/2 mice were indeed the consequence of increased production of this cytokine in Adap 2/2 CD8 + T cells. Mueller et al. [25] also reported data from adoptive CD4 + T cell transfers. In support of our findings-that CD4 + T cells are more dependent on ADAP than CD8 + T cells-Adap 2/2 CD4 + T cells proliferated and expanded less than their WT counterparts in this in vivo setting. This further substantiates our argument for differential dependence on ADAP between T cell subsets. Interestingly, they reported no differences for the expression of CD25, CD69, and CD62L. Why in certain in vitro and in vivo settings CD69, CD25, and IFN-g are affected by loss of ADAP in CD8 + T cells, whereas the other assessed markers were not, remains elusive. One possible explanation is that the promoter regions of CD25 and IFN-g are strikingly similar [54] and that their transcription requires a concerted action of the transcription factors AP-1, NF-kB, NFAT1, and T-bet [55] [56] [57] [58] [59] [60] . Cell-cycle progression and subsequent proliferation rely heavily on NF-kB activation, mediated by the CBM signalosome [18] . On the other hand, induction of CD69 seems to rely solely on NFAT. Taken together, this suggests that ADAP might be dispensable for the activation of transcription factors AP-1 and NF-kB but vital for NFAT1-mediated transcription in CD8 + T cells. Rajasekaran et al. [61] have recently shown that whereas cytokine production in NK cells after NKG2D and CD137 stimulation is strongly dependent on ADAP-mediated formation of the CBM signalosome, cytotoxicity of the cells does not rely on the adaptor protein. In vitro analysis of the cytotoxicity against allogenic target cells also revealed no differences between WT and ADAP-deficient cytotoxic lymphocytes [19] . As in our experiments, granzyme B production, a hallmark of CD8 + T cell cytotoxicity, is not affected by ADAP deficiency, whereas IFN-g expression is severely decreased in both in vivo-adoptive transfer infection models used in our study, we may speculate that similar mechanisms are at play in CD8 + T cells. Taken together, we present comprehensive in vitro, as well as in vivo, data showing that CD4 + and CD8 + T cells differentially rely on ADAP-mediated signaling downstream of the TCR. Whereas CD4 + T cells are strongly dependent on ADAP, in terms of their TCRmediated activation, proliferation, adhesion, and thymic selection, CD8 + T cells are hardly affected by ADAP deficiency and retain most of their function. This might highlight ADAP as a potential molecular target for T cell subset-specific, targeted therapeutic interventions. Autoreactive CD4 + T cells are well known to orchestrate detrimental immune responses in autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. Thus, one may speculate that an ADAP inhibitor would affect CD4 + T cell function, thereby potentially reducing disease burden, whereas at the same time, CD8 + T cell responses, including tumor surveillance and pathogen control, would largely remain unaffected. AUTHORSHIP G.P.P., M.G., S.K., and A.R. designed and performed research, analyzed data, and wrote the paper. O.H., M.A., and L.P. performed research and analyzed data. B.S. and D.B. designed the research and wrote the paper.
